-
1
-
-
0034707105
-
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group
-
Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000;343: 1520-1528.
-
(2000)
N Engl J Med
, vol.343
, pp. 1520-1528
-
-
Bombardier, C.1
Laine, L.2
Reicin, A.3
Shapiro, D.4
Burgos-Vargas, R.5
Davis, B.6
Day, R.7
Ferraz, M.B.8
Hawkey, C.J.9
Hochberg, M.C.10
Kvien, T.K.11
Schnitzer, T.J.12
-
2
-
-
19744380776
-
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
-
Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005;352:1092-1102.
-
(2005)
N Engl J Med
, vol.352
, pp. 1092-1102
-
-
Bresalier, R.S.1
Sandler, R.S.2
Quan, H.3
Bolognese, J.A.4
Oxenius, B.5
Horgan, K.6
Lines, C.7
Riddell, R.8
Morton, D.9
Lanas, A.10
Konstam, M.A.11
Baron, J.A.12
-
3
-
-
14944371100
-
Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery
-
Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, Boyce SW, Verburg KM. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 2005;352:1081-1091.
-
(2005)
N Engl J Med
, vol.352
, pp. 1081-1091
-
-
Nussmeier, N.A.1
Whelton, A.A.2
Brown, M.T.3
Langford, R.M.4
Hoeft, A.5
Parlow, J.L.6
Boyce, S.W.7
Verburg, K.M.8
-
4
-
-
20144365496
-
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
-
Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005;352: 1071-1080.
-
(2005)
N Engl J Med
, vol.352
, pp. 1071-1080
-
-
Solomon, S.D.1
McMurray, J.J.2
Pfeffer, M.A.3
Wittes, J.4
Fowler, R.5
Finn, P.6
Anderson, W.F.7
Zauber, A.8
Hawk, E.9
Bertagnolli, M.10
-
5
-
-
33749339372
-
Cardiovascular risk and inhibition of cyclooxygenase: A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2
-
McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 2006;296:1633-1644.
-
(2006)
JAMA
, vol.296
, pp. 1633-1644
-
-
McGettigan, P.1
Henry, D.2
-
6
-
-
33744976771
-
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
-
Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006;332:1302-1308.
-
(2006)
BMJ
, vol.332
, pp. 1302-1308
-
-
Kearney, P.M.1
Baigent, C.2
Godwin, J.3
Halls, H.4
Emberson, J.R.5
Patrono, C.6
-
7
-
-
22444441665
-
Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: Population based nested case-control analysis
-
Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005;330:1366.
-
(2005)
BMJ
, vol.330
, pp. 1366
-
-
Hippisley-Cox, J.1
Coupland, C.2
-
8
-
-
70349739937
-
Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease
-
Ray WA, Varas-Lorenzo C, Chung CP, Castellsague J, Murray KT, Stein CM, Daugherty JR, Arbogast PG, Garcia-Rodriguez LA. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes 2009;2:155-163.
-
(2009)
Circ Cardiovasc Qual Outcomes
, vol.2
, pp. 155-163
-
-
Ray, W.A.1
Varas-Lorenzo, C.2
Chung, C.P.3
Castellsague, J.4
Murray, K.T.5
Stein, C.M.6
Daugherty, J.R.7
Arbogast, P.G.8
Garcia-Rodriguez, L.A.9
-
9
-
-
33747125484
-
Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction
-
Gislason GH, Jacobsen S, Rasmussen JN, Rasmussen S, Buch P, Friberg J, Schramm TK, Abildstrom SZ, Kober L, Madsen M, Torp-Pedersen C. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation 2006;113:2906-2913.
-
(2006)
Circulation
, vol.113
, pp. 2906-2913
-
-
Gislason, G.H.1
Jacobsen, S.2
Rasmussen, J.N.3
Rasmussen, S.4
Buch, P.5
Friberg, J.6
Schramm, T.K.7
Abildstrom, S.Z.8
Kober, L.9
Madsen, M.10
Torp-Pedersen, C.11
-
10
-
-
13444263619
-
Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal antiinflammatory drugs: Nested case-control study
-
Graham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G, Shoor S, Ray WA. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal antiinflammatory drugs: nested case-control study. Lancet 2005;365:475-481.
-
(2005)
Lancet
, vol.365
, pp. 475-481
-
-
Graham, D.J.1
Campen, D.2
Hui, R.3
Spence, M.4
Cheetham, C.5
Levy, G.6
Shoor, S.7
Ray, W.A.8
-
11
-
-
77956976489
-
Long-term use of anti-inflammatory drugs and risk of atrial fibrillation
-
De Caterina R, Ruigomez A, Rodriguez LA. Long-term use of anti-inflammatory drugs and risk of atrial fibrillation. Arch Intern Med 2010;170:1450-1455.
-
(2010)
Arch Intern Med
, vol.170
, pp. 1450-1455
-
-
De Caterina, R.1
Ruigomez, A.2
Rodriguez, L.A.3
-
12
-
-
79960089980
-
Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: Population based case-control study
-
Schmidt M, Christiansen CF, Mehnert F, Rothman KJ, Sorensen HT. Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study. BMJ 2011;343:d3450.
-
(2011)
BMJ
, vol.343
-
-
Schmidt, M.1
Christiansen, C.F.2
Mehnert, F.3
Rothman, K.J.4
Sorensen, H.T.5
-
13
-
-
0034753453
-
A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden
-
Hammar N, Alfredsson L, Rosen M, Spetz CL, Kahan T, Ysberg AS. A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol 2001;30 (Suppl. 1):S30-S34.
-
(2001)
Int J Epidemiol
, vol.30
, Issue.SUPPL. 1
-
-
Hammar, N.1
Alfredsson, L.2
Rosen, M.3
Spetz, C.L.4
Kahan, T.5
Ysberg, A.S.6
-
14
-
-
84970316295
-
Validity of register data on acute myocardial infarction and acute stroke: The Skaraborg Hypertension Project
-
Lindblad U, Rastam L, Ranstam J, Peterson M. Validity of register data on acute myocardial infarction and acute stroke: the Skaraborg Hypertension Project. Scand J Soc Med 1993;21:3-9.
-
(1993)
Scand J Soc Med
, vol.21
, pp. 3-9
-
-
Lindblad, U.1
Rastam, L.2
Ranstam, J.3
Peterson, M.4
-
16
-
-
0034644396
-
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study
-
Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000;284:1247-1255.
-
(2000)
JAMA
, vol.284
, pp. 1247-1255
-
-
Silverstein, F.E.1
Faich, G.2
Goldstein, J.L.3
Simon, L.S.4
Pincus, T.5
Whelton, A.6
Makuch, R.7
Eisen, G.8
Agrawal, N.M.9
Stenson, W.F.10
Burr, A.M.11
Zhao, W.W.12
Kent, J.D.13
Lefkowith, J.B.14
Verburg, K.M.15
Geis, G.S.16
-
17
-
-
33749337137
-
Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: Meta-analysis of randomized trials
-
Zhang J, Ding EL, Song Y. Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials. JAMA 2006;296: 1619-1632.
-
(2006)
JAMA
, vol.296
, pp. 1619-1632
-
-
Zhang, J.1
Ding, E.L.2
Song, Y.3
-
18
-
-
0346995016
-
Inflammation as a risk factor for atrial fibrillation
-
Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS, Chung MK. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006-3010.
-
(2003)
Circulation
, vol.108
, pp. 3006-3010
-
-
Aviles, R.J.1
Martin, D.O.2
Apperson-Hansen, C.3
Houghtaling, P.L.4
Rautaharju, P.5
Kronmal, R.A.6
Tracy, R.P.7
Van Wagoner, D.R.8
Psaty, B.M.9
Lauer, M.S.10
Chung, M.K.11
-
19
-
-
77954795973
-
A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women
-
Conen D, Ridker PM, Everett BM, Tedrow UB, Rose L, Cook NR, Buring JE, Albert CM. A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J 2010;31:1730-1736.
-
(2010)
Eur Heart J
, vol.31
, pp. 1730-1736
-
-
Conen, D.1
Ridker, P.M.2
Everett, B.M.3
Tedrow, U.B.4
Rose, L.5
Cook, N.R.6
Buring, J.E.7
Albert, C.M.8
-
20
-
-
31044441042
-
Biological basis for the cardiovascular consequences of COX-2 inhibition: Therapeutic challenges and opportunities
-
Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 2006;116:4-15.
-
(2006)
J Clin Invest
, vol.116
, pp. 4-15
-
-
Grosser, T.1
Fries, S.2
Fitzgerald, G.A.3
-
21
-
-
33750318519
-
COX-2 and the kidney
-
Harris RC. COX-2 and the kidney. J Cardiovasc Pharmacol 2006;47 (Suppl. 1): S37-S42.
-
(2006)
J Cardiovasc Pharmacol
, vol.47
, Issue.SUPPL. 1
-
-
Harris, R.C.1
-
22
-
-
70350455495
-
Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits
-
Foudi N, Norel X, Rienzo M, Louedec L, Brink C, Michel JB, Bäck M. Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits. Am J Physiol Heart Circ Physiol 2009;297: H1882-H1888.
-
(2009)
Am J Physiol Heart Circ Physiol
, vol.297
-
-
Foudi, N.1
Norel, X.2
Rienzo, M.3
Louedec, L.4
Brink, C.5
Michel, J.B.6
Bäck, M.7
-
23
-
-
77954084036
-
Targeted deletions of cyclooxygenase-2 and atherogenesis in mice
-
Hui Y, Ricciotti E, Crichton I, Yu Z, Wang D, Stubbe J, Wang M, Pure E, FitzGerald GA. Targeted deletions of cyclooxygenase-2 and atherogenesis in mice. Circulation 2010;121:2654-2660.
-
(2010)
Circulation
, vol.121
, pp. 2654-2660
-
-
Hui, Y.1
Ricciotti, E.2
Crichton, I.3
Yu, Z.4
Wang, D.5
Stubbe, J.6
Wang, M.7
Pure, E.8
Fitzgerald, G.A.9
-
24
-
-
0019793560
-
Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias
-
Coker SJ, Parratt JR, Ledingham IM, Zeitlin IJ. Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature 1981; 291:323-324.
-
(1981)
Nature
, vol.291
, pp. 323-324
-
-
Coker, S.J.1
Parratt, J.R.2
Ledingham, I.M.3
Zeitlin, I.J.4
-
25
-
-
0025088119
-
Pericardial prostaglandin biosynthesis prevents the increased incidence of reperfusion-induced ventricular fibrillation produced by efferent sympathetic stimulation in dogs
-
Miyazaki T, Zipes DP. Pericardial prostaglandin biosynthesis prevents the increased incidence of reperfusion-induced ventricular fibrillation produced by efferent sympathetic stimulation in dogs. Circulation 1990;82:1008-1019.
-
(1990)
Circulation
, vol.82
, pp. 1008-1019
-
-
Miyazaki, T.1
Zipes, D.P.2
-
26
-
-
0025023606
-
Prostaglandins in the pericardial fluid modulate neural regulation of cardiac electrophysiological properties
-
Miyazaki T, Pride HP, Zipes DP. Prostaglandins in the pericardial fluid modulate neural regulation of cardiac electrophysiological properties. Circ Res 1990;66: 163-175.
-
(1990)
Circ Res
, vol.66
, pp. 163-175
-
-
Miyazaki, T.1
Pride, H.P.2
Zipes, D.P.3
-
27
-
-
0019729165
-
The effects of prostaglandins E2, F2 alpha, prostacyclin, flurbiprofen and aspirin on arrhythmias resulting from coronary artery ligation in anaesthetized rats
-
Coker SJ, Parratt JR. The effects of prostaglandins E2, F2 alpha, prostacyclin, flurbiprofen and aspirin on arrhythmias resulting from coronary artery ligation in anaesthetized rats. Br J Pharmacol 1981;74:155-159.
-
(1981)
Br J Pharmacol
, vol.74
, pp. 155-159
-
-
Coker, S.J.1
Parratt, J.R.2
-
28
-
-
66149138017
-
Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function
-
Wang D, Patel VV, Ricciotti E, Zhou R, Levin MD, Gao E, Yu Z, Ferrari VA, Lu MM, Xu J, Zhang H, Hui Y, Cheng Y, Petrenko N, Yu Y, FitzGerald GA. Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function. Proc Natl Acad Sci USA 2009;106:7548-7552.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 7548-7552
-
-
Wang, D.1
Patel, V.V.2
Ricciotti, E.3
Zhou, R.4
Levin, M.D.5
Gao, E.6
Yu, Z.7
Ferrari, V.A.8
Lu, M.M.9
Xu, J.10
Zhang, H.11
Hui, Y.12
Cheng, Y.13
Petrenko, N.14
Yu, Y.15
Fitzgerald, G.A.16
-
29
-
-
38349110209
-
Inhibition of delayed rectifier potassium channels and induction of arrhythmia: A novel effect of celecoxib and the mechanism underlying it
-
Frolov RV, Berim IG, Singh S. Inhibition of delayed rectifier potassium channels and induction of arrhythmia: a novel effect of celecoxib and the mechanism underlying it. J Biol Chem 2008;283:1518-1524.
-
(2008)
J Biol Chem
, vol.283
, pp. 1518-1524
-
-
Frolov, R.V.1
Berim, I.G.2
Singh, S.3
-
30
-
-
41449117606
-
Celecoxib modulates hypertrophic signalling and prevents load-induced cardiac dysfunction
-
Jacobshagen C, Gruber M, Teucher N, Schmidt AG, Unsold BW, Toischer K, Nguyen VP, Maier LS, Kogler H, Hasenfuss G. Celecoxib modulates hypertrophic signalling and prevents load-induced cardiac dysfunction. Eur J Heart Fail 2008;10: 334-342.
-
(2008)
Eur J Heart Fail
, vol.10
, pp. 334-342
-
-
Jacobshagen, C.1
Gruber, M.2
Teucher, N.3
Schmidt, A.G.4
Unsold, B.W.5
Toischer, K.6
Nguyen, V.P.7
Maier, L.S.8
Kogler, H.9
Hasenfuss, G.10
-
31
-
-
77957282609
-
Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries
-
Goyal A, Bhatt DL, Steg PG, Gersh BJ, Alberts MJ, Ohman EM, Corbalan R, Eagle KA, Gaxiola E, Gao R, Goto S, D'Agostino RB, Califf RM, Smith SC Jr, Wilson PW. Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries. Circulation 2010;122:1167-1175.
-
(2010)
Circulation
, vol.122
, pp. 1167-1175
-
-
Goyal, A.1
Bhatt, D.L.2
Steg, P.G.3
Gersh, B.J.4
Alberts, M.J.5
Ohman, E.M.6
Corbalan, R.7
Eagle, K.A.8
Gaxiola, E.9
Gao, R.10
Goto, S.11
D'agostino, R.B.12
Califf, R.M.13
Smith Jr., S.C.14
Wilson, P.W.15
-
32
-
-
78650420190
-
Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous Holter monitoring in patients with cerebral ischemia presenting in sinus rhythm
-
Stahrenberg R, Weber-Kruger M, Seegers J, Edelmann F, Lahno R, Haase B, Mende M, Wohlfahrt J, Kermer P, Vollmann D, Hasenfuss G, Groschel K, Wachter R. Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous Holter monitoring in patients with cerebral ischemia presenting in sinus rhythm. Stroke 2010;41:2884-2888.
-
(2010)
Stroke
, vol.41
, pp. 2884-2888
-
-
Stahrenberg, R.1
Weber-Kruger, M.2
Seegers, J.3
Edelmann, F.4
Lahno, R.5
Haase, B.6
Mende, M.7
Wohlfahrt, J.8
Kermer, P.9
Vollmann, D.10
Hasenfuss, G.11
Groschel, K.12
Wachter, R.13
|